MCR - Appalaches

A Phase II Study of Adjuvant PALbociclib as an Alternative to CHemotherapy in Elderly patientS With High-risk ER+/HER2- Early Breast Cancer.

PHASE

II

NCT Number

NCT03609047

DEFINITION

Pharmacological

SPONSOR

EORTC GSO